Reichl S, Müller-Goymann CC (January 2003). "The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride". International Journal of Pharmaceutics. 250 (1): 191–201. doi:10.1016/S0378-5173(02)00541-0. PMID12480285.
Takayanagi I, Koike K (January 1985). "A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs". General Pharmacology. 16 (3): 265–267. doi:10.1016/0306-3623(85)90080-1. PMID2862092.
Reichl S, Müller-Goymann CC (January 2003). "The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride". International Journal of Pharmaceutics. 250 (1): 191–201. doi:10.1016/S0378-5173(02)00541-0. PMID12480285.
Takayanagi I, Koike K (January 1985). "A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs". General Pharmacology. 16 (3): 265–267. doi:10.1016/0306-3623(85)90080-1. PMID2862092.
US 3853923, Ito K, Ikemoto M, Kimura K, Nakanishi T, "2-Substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans", issued 1974, assigned to Kakenyaku Kako KK
thieme.com
pharmaceutical-substances.thieme.com
"Befunolol". Pharmaceutical Substances. Georg Thieme Verlag KG. Retrieved 2024-07-01.